The AI workspace for legal professionals
- Legal research with access to more than 1 million sources
- Document automation
- Matter management
- Hosted in the EU and Switzerland
Try it free for 14 days (10 questions/day during trial)
The AI workspace for legal professionals
Try it free for 14 days (10 questions/day during trial)
2011-1095•Aventis Pharma S.a. and Sanofi-Aventis U.s., LLC v. Sun Pharmaceutical Industries, Ltd. and Sun Pharma Global Fze
2011-1095Court of Appeals for the Federal CircuitAug 7, 2012
# NOTE: This order is nonprecedential. United States Court of Appeals for the Federal Circuit
AVENTIS PHARMA S.A. AND SANOFI-AVENTIS
U.S., LLC,
Plaintiffs-Appellants,
v.
SUN PHARMACEUTICAL INDUSTRIES, LTD. AND
SUN PHARMA GLOBAL FZE,
Defendants-Appellees.
2011-1095
Appeal from the United States District Court for the
District of Delaware in case no. 09-CV-0630, Chief Judge
Gregory M. Sleet.
## ON MOTION
Before LOURIE, SCHALL and DYK, Circuit Judges.
LOURIE, Circuit Judge.
ORDER
The court construes Aventis Pharma S.A. and Sanofi-
Aventis U.S., LLC ("Aventis")'s response to this court's
February 4, 2011 order as an unopposed motion to lift the
<!-- PageBreak -->
<!-- PageHeader="AVENTIS PHARMA v. SUN PHARMA" -->
stay and summarily affirm the judgment of the United
States District Court for the District of Delaware.
This appeal arises out of a complaint filed by Aventis
in the district court alleging infringement of U.S. Patent
Nos. 5,714,512B1 and 5,750,561. In a related case,
Aventis Pharma S.A. v. Hospira, Inc., 07-CV-0721 (D. Del.
2010) (Hospira), the district court found that the same
patent claims asserted in this case were invalid and
unenforceable due to inequitable conduct. In light of
Hospira, the district court entered final judgment in this
case against Aventis, and Aventis appealed to this court.
This court stayed proceedings pending final disposition of
Hospira.
On April 9, 2012, this court affirmed the district
court's judgment in Hospira. See Aventis Pharma S.A. v.
Hospira, Inc., 675 F.3d 1324 (Fed. Cir. 2012). In light of
this court's decision in Hospira, Aventis concedes that the
district court's judgment in this case should be consistent
with Hospira.
Accordingly,
IT IS ORDERED THAT:
(1) The motion is granted. The stay is lifted and the
judgment of the district court is affirmed.
(2) Each side shall bear its own costs.
(3) All pending motions are moot.
FOR THE COURT
AUG 0 7-2012
Date
/s/ Jan Horbaly
Jan Horbaly
Clerk
FILED
U.S. COURT OF APPEALS FOR
THE FEDERAL CIRCUIT
AUG 0 7 2012
JAN HORBALY
CLERK
<!-- PageBreak -->
<!-- PageHeader="AVENTIS PHARMA v. SANDOZ" -->
cc: George F. Pappas, Esq.
Robert B. Breisblatt, Esq.
s25
Connect Omnilex to search the legal corpus from your AI assistant.